Melissa Panteliodis
NPI 1770143729 · Allergy & Immunology Physician · Pinellas Park, FL
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1770143729
- Entity type
- Individual
- Primary specialty
- Allergy & Immunology PhysicianAllopathic & Osteopathic Physicians
- Sex
- Female
- Sole proprietor
- No
- License
- APRN11002707 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
6 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
169 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 62 | $12 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 39 | $75 |
| Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060 | 19 | $31 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 18 | $106 |
| Administration and Interpretation of Patient-Focused Health Risk Assessment96160 | 16 | $2 |
| Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, 1 Hour Or Less96365 | 15 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Azelastine Hcl | 51 | 27 |
| Montelukast Sodium | 50 | 18 |
| Fluticasone Propionate | 42 | 19 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 40 | 16 |
| Budesonide/Formoterol Fumaratebrand: Symbicort | 23 | — |
| Budesonide/Glycopyr/Formoterolbrand: Breztri Aerosphere | 16 | — |
| Fluticasone/Umeclidin/Vilanter |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,264 across 46 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2019-06-20
- Last updated
- 2024-11-25
- Certified
- 2024-11-25
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.